Comprehensive Cardiac MRI Therapy is a Must for Cardiac Safety

Comprehensive Cardiac MRI Therapy is a Must for Cardiac Safety

Pamela Woodard, MD, Washington University radiologist, presents an overview and update on how cardiac MRI can provide cardiac assessment and management of patients undergoing chemotherapy, to include accurate assessment of baseline and post-chemotherapy left ventricular systolic function (LVEF) and demonstration of baseline and post-chemotherapy myocardial scarring/fibrosis. In addition cardiac MRI has the potential to predict myocardial dysfunction by assessment of pre- and post-treatment measurement of longitudinal and circumferential strain and through assessment of native (non-contrast) and post-contrast T1-mapping and extracellular volume (ECV). 


Created by

Medical Professional Education Center

Presenters

Pamela Woodard, MD

Pamela Woodard, MD

Professor of Radiology,
Washington University School of Medicine

Pamela Woodard, MD, is a professor of radiology and biomedical engineering and senior vice chair and division director of Radiology Research Facilities. Her areas of specialty include cardiac CT and MRI, and pulmonary embolism diagnosis.

View full profile